NICO inhibits PARP-1 over activation, preventing excessive NAD+ and ATP depletion, thereby reducing β-cell necrosis and resulting in partial insulin deficiency and hypoinsulinemia [29,30]. The gene discussed is PARP1; the disease is Hypoinsulinemia.